HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HBA Expo In Brief

This article was originally published in The Rose Sheet

Executive Summary

Alchimie Forever on spa and salon market: Selling skin-care products through salons and spas has the potential to reach more consumers than through specialty retail channels, according to Ada Polla, president and CEO of skin-care line Alchimie Forever. The approximately 18,000 day spas and 1,500 medical spas in North America also feature less competition than specialty retailers, each carrying five to seven lines, rather than hundreds. "When you sell your skin-care line through spa or salon, the estheticians and the therapists become your brand ambassadors. They're selling and recommending the products" used during treatments, Polla said at the HBA Global Expo in New York in a session entitled "Marketing Through Salons, Day Spas and Medical Spas." At retail, public relations and "the fact that Beyonce loves the product" are essential to generating sales, the exec said. She noted one of the downsides to selling products through the salon and spa channel - the fragmented nature of the industry. "It takes a lot of time and a lot of patience" to sell to each location, whereas in specialty retail, "I could have a meeting with one person and have products in 157 stores." Alchimie Forever's 18-SKU line is sold at salons, spas and specialty retailers in North America and Europe and at Alchimie-Forever.com

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016453

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel